Device Oncology

Intelliblate Microwave Ablation System Console

Payments companies reported to CMS as associated with Intelliblate Microwave Ablation System Console. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$13Kassociated payments (2023-2025)
35clinicians with associated payments
1company reporting

By year

2025 $13K

Payments reported as associated with Intelliblate Microwave Ablation System Console, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Diagnostic Radiology $6,896
Vascular & Interventional Radiology $5,338
Family $198
Blood Banking & Transfusion Medicine $168
Physician Assistant $20.97

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Intelliblate Microwave Ablation System Console

These are the largest totals companies reported as associated with Intelliblate Microwave Ablation System Console. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Pratik Shukla Newark, NJ Diagnostic Radiology $2,580.00
Kirema Garcia-Reyes Atlanta, GA Vascular & Interventional Radiology $2,400.00
Jordan Tasse Maywood, IL Vascular & Interventional Radiology $2,000.00
Constantinos Sofocleous New York, NY Diagnostic Radiology $1,860.00
Brian Welch Rochester, MN Diagnostic Radiology $1,000.00
Steven Raman Los Angeles, CA Vascular & Interventional Radiology $230.70
Sonia Gupta Philadelphia, PA Diagnostic Radiology $198.13
Jessica Stewart Los Angeles, CA Vascular & Interventional Radiology $198.13
Olivia Kulig-Kort Los Angeles, CA Family $198.13
John Brunner Roseville, MN Diagnostic Radiology $168.20

Prescribed Intelliblate Microwave Ablation System Console?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.